|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 04749051.1 (espacenet) (Federated) (European Patent Register), 20040623 | Patent/reg. no. and date | DK/EP 1641793, 20080213 | Publication date | 20060405 | Priority no. and date | SE 0301904, 20030626 | EP pub. no. and date |
EP 1641793 20060405 | Effective date | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | Applicant ref. no. | | Inventor | NORDBERG, Peter, AstraZeneca R & D Mölndal
S-431 83 Mölndal, SE | Representative | | Opponent | | IPC Class | A61K 31/437 (2006.01) , A61P 1/04 (2006.01) , C07D 471/04 (2006.01) | Title | Hidtil ukendt imidazopyridinforbindelse II med terpeutisk effekt | Int. application no. | SE2004001013 | Int. publication no. | WO2004113339 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |